Three-year follow-up after transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia using the PRIMUS U + R device.
Scand J Urol Nephrol
; 33(4): 217-21, 1999 Aug.
Article
en En
| MEDLINE
| ID: mdl-10515082
ABSTRACT
OBJECTIVE:
We report long-term (3 years) follow-up data of transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia (BPH) using a lower-power treatment protocol. MATERIAL ANDMETHODS:
Ninety-one patients were treated in a 1-h session with the PRIMUS U + R device.RESULTS:
Forty-five of the patients were still on TUMT monotherapy at 3-year follow-up, while 32 received additional therapy for their lower urinary tract symptoms. In patients with monotherapy there was a 45% decrease in international prostate symptom score (IPSS) when compared to pretreatment values. The moderate increase in peak uroflow seen early after TUMT could not be observed after 3 years. No serious side-effects were seen.CONCLUSION:
Three years after lower-power TUMT, 49% of patients treated were on TUMT monotherapy, while 35% received additional therapy for their voiding symptoms. Symptom score decreased 45% in patients with TUMT monotherapy concomitant with unchanged uroflow.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Hiperplasia Prostática
/
Hipertermia Inducida
/
Microondas
Tipo de estudio:
Diagnostic_studies
/
Evaluation_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
Límite:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Scand J Urol Nephrol
Año:
1999
Tipo del documento:
Article
País de afiliación:
Noruega